ALTSHULER DAVID — SEC Form 4 filings
SEC reporting owner CIK 1550395. 19 Form 4 filings on record with FilingPulse; latest filed 2026-01-26.
Transaction summary — filings shown
Covers all 19 filings on record, filed 2024-02-08 to 2026-01-26. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 13 legs across 13 filings — 27,433 shares, $12,527,070 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 16.
- Largest priced transaction: sale of 4,239 shares @ $425.70 ($1,804,542) in VERTEX PHARMACEUTICALS INC / MA, filed 2024-02-27.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Scientific Officer | 19 | — | 13 legs · 27,433 sh · $12,527,070 | 16 |
Form 4 filings — ALTSHULER DAVID
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-01-26 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 7,866 @ $0 · Grant/award (A): 3,328 @ $0 | EDGAR |
| 2025-05-19 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 52 @ $424.69 | EDGAR |
| 2025-03-17 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 3,231 @ $510 | EDGAR |
| 2025-03-12 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 3,231 @ $500 | EDGAR |
| 2025-03-05 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 3,231 @ $490 | EDGAR |
| 2025-02-28 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 5,954 @ $479.61 · Sale (S): 1,272 @ $480 | EDGAR |
| 2025-02-26 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 3,971 @ $483.28 · Sale (S): 848 @ $480.95 | EDGAR |
| 2025-02-24 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 1,111 @ $480 | EDGAR |
| 2025-02-19 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 2,293 @ $463.46 | EDGAR |
| 2025-02-14 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 5,324 @ $0 | EDGAR |
| 2025-02-12 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 2,142 @ $467.98 | EDGAR |
| 2025-02-06 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 12,314 @ $0 · Grant/award (A): 7,114 @ $0 | EDGAR |
| 2024-11-19 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 15 @ $478.56 | EDGAR |
| 2024-05-17 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 54 @ $430.93 | EDGAR |
| 2024-02-27 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 3,970 @ $431.79 · Sale (S): 4,239 @ $425.70 | EDGAR |
| 2024-02-23 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 3,002 @ $421.77 | EDGAR |
| 2024-02-21 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 3,750 @ $424.01 · Tax withholding (F): 2,812 @ $420.58 · Sale (S): 4,002 @ $420.79 | EDGAR |
| 2024-02-13 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 2,099 @ $422.74 · Sale (S): 3,145 @ $420.24 | EDGAR |
| 2024-02-08 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 5,814 @ $0 · Grant/award (A): 7,866 @ $0 · Grant/award (A): 7,114 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1550395 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →